Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Leukemia

Free Subscription Articles published in Cancer Chemother Pharmacol Retrieve available abstracts of 13 articles: HTML format Text format

Single Articles

December 2009
1. ADAM DE BEAUMAIS T , Dervieux T, Fakhoury M, Medard Y, et al
   The impact of high-dose methotrexate on intracellular 6-mercaptopurine disposition during interval therapy of childhood acute lymphoblastic leukemia.
   Cancer Chemother Pharmacol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   September 2009
2. CONROY A , Stockett DE, Walker D, Arkin MR, et al
   SNS-032 is a potent and selective CDK 2, 7 and 9 inhibitor that drives target modulation in patient samples.
   Cancer Chemother Pharmacol. 2009;64:723-32.
   PubMed     Text format     Related articles    Abstract available
   
   
   July 2009
3. PARKER WB , Shaddix SC, Gilbert KS, Shepherd RV, et al
   Enhancement of the in vivo antitumor activity of clofarabine by 1-beta-D-[4-thio-arabinofuranosyl]-cytosine.
   Cancer Chemother Pharmacol. 2009;64:253-61.
   PubMed     Text format     Related articles    Abstract available
   
   
   June 2009
4. BRECCIA M , Frustaci AM, Cannella L, Soverini S, et al
   Sequential development of mutant clones in an imatinib resistant chronic myeloid leukaemia patient following sequential treatment with multiple tyrosine kinase inhibitors: an emerging problem?
   Cancer Chemother Pharmacol. 2009;64:195-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   March 2009
5. ASCIONE A , Cianfriglia M, Dupuis ML, Mallano A, et al
   The glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol overcomes the MDR1-P-glycoprotein and MRP1-mediated multidrug resistance in acute myeloid leukemia cells.
   Cancer Chemother Pharmacol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2009
6. LEMAIRE M , Momparler LF, Raynal NJ, Bernstein ML, et al
   Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine.
   Cancer Chemother Pharmacol. 2009;63:411-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2009
7. ASANO T , Tsutsuda-Asano A, Fukunaga Y
   Indomethacin overcomes doxorubicin resistance by decreasing intracellular content of glutathione and its conjugates with decreasing expression of gamma-glutamylcysteine synthetase via promoter activity in doxorubicin-resistant leukemia cells.
   Cancer Chemother Pharmacol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. MENON-ANDERSEN D , Mondick JT, Jayaraman B, Thompson PA, et al
   Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults.
   Cancer Chemother Pharmacol. 2009;63:229-38.
   PubMed     Text format     Related articles    Abstract available
   
   
   November 2008
9. MAURITZ R , Peters GJ, Kathmann I, Teshale H, et al
   Dynamics of antifolate transport via the reduced folate carrier and the membrane folate receptor in murine leukaemia cells in vitro and in vivo.
   Cancer Chemother Pharmacol. 2008;62:937-48.
   PubMed     Text format     Related articles    Abstract available
   
   
   October 2008
10. MUNKELT D , Koehl U, Kloess S, Zimmermann SY, et al
    Cytotoxic effects of treosulfan and busulfan against leukemic cells of pediatric patients.
    Cancer Chemother Pharmacol. 2008;62:821-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
11. ANUCHAPREEDA S , Tima S, Duangrat C, Limtrakul P, et al
    Effect of pure curcumin, demethoxycurcumin, and bisdemethoxycurcumin on WT1 gene expression in leukemic cell lines.
    Cancer Chemother Pharmacol. 2008;62:585-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
12. STONE RM , Donohue KA, Stock W, Hars V, et al
    A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804.
    Cancer Chemother Pharmacol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
13. BARTLETT NL , Johnson JL, Wagner-Johnston N, Ratain MJ, et al
    Phase II study of 9-aminocamptothecin in previously treated lymphomas: results of Cancer and Leukemia Group B 9551.
    Cancer Chemother Pharmacol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: